# Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

> **NCT06836219** · — · RECRUITING · sponsor: **Consorzio Oncotech** · enrollment: 300 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06836219
- **Lead sponsor:** Consorzio Oncotech
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-13
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836219, "Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06836219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*